Peripal develops and commercializes a patient aid for the chronic patient population in dialysis, supporting a critical therapy step: the manual connection of tubings.

Dialysis will further increase healthcare burden driven by diabetes, age, and hypertension. Said chronic patient population is growing at 2-4% annually, driven by age, diabetes, and hypertension.

The use of peritoneal dialysis differs across markets from 5% to 35% of patients, worldwide 11% or 300’000 patients dialyse at home. Home dialysis is performed at different intensity due to incentives of healthcare systems and reimbursement levels.

Currently about 5-6% of the worldwide dialysis expenditures of USD 80bn - an estimate of USD 4bn is spent on products for home dialysis.